Intranasal Delivery of Gallium–Quercetin Nanoparticles for Multi‐Target Ferroptosis Inhibition in Parkinson's Disease
Advanced Science · 2026
DOI: 10.1002/advs.77025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Keyang Xu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The First Affiliated Hospital of Soochow University, School of Radiation Medicine and Protection, Soochow University, Suzhou…. Hauptthemen laut MEDLINE: Quercetin, Ferroptosis, Gallium, Parkinson Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Suzhou Fundamental Research Project.
Abstract (Originalsprache)
Ferroptosis contributes to Parkinson's disease (PD) through interconnected processes including iron dysregulation, oxidative stress, and mitochondrial dysfunction, yet current therapies targeting single pathways remain insufficient. Herein, we developed gallium–quercetin nanoparticles (GQNPs) as an intranasally deliverable nanoplatform for multi‐target ferroptosis inhibition. In vitro, GQNPs suppressed ferroptosis by coordinating iron regulation and antioxidation. Ga 3 + interfered with transferrin‐mediated iron uptake to restrict iron influx, while quercetin reduced oxidative stress and supported iron homeostasis, thereby decreasing ROS accumulation and improving mitochondrial function. In vivo, intranasal delivery of GQNPs effectively bypassed the blood‐brain barrier to recover motor coordination and cognitive function in PD mice. By integrating iron regulation, antioxidant activity, and mitochondrial protection within a single nanoplatform, this work highlights gallium‐based coordination nanoparticles as a promising therapeutic strategy for ferroptosis‐associated neurodegenerative diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, The First Affiliated Hospital of Soochow University, School of Radiation Medicine and Protection, Soochow University, Suzhou, China.
- General Dentistry Department, The Stomatology Hospital Affiliated of Suzhou Vocational Health College, Suzhou, China.
- Medical School of Nanjing University, Nanjing, China.
- The Second Affiliated Hospital of Soochow University, Suzhou, China.
- Biomedical Basic Research Center (BBRC) of Jiangsu Province, Suzhou, China.
- School of Life Sciences, Soochow University, Suzhou, China.
ORCID-Profile: Bingbing Bai, Caide Liu, Shuhua Wu, Jianfeng Zeng
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Suzhou Fundamental Research Project
Zitieren
APA
Xu, K., Kou, D., Xiao, X., Bai, B., Liu, C., Wu, M., Shi, Y., Xu, M., Cao, X., Qi, H., Wu, S., Zeng, J., & Gao, M. (2026). Intranasal Delivery of Gallium–Quercetin Nanoparticles for Multi‐Target Ferroptosis Inhibition in Parkinson's Disease. Advanced Science. https://doi.org/10.1002/advs.77025
Vancouver
Xu K, Kou D, Xiao X, Bai B, Liu C, Wu M, et al. Intranasal Delivery of Gallium–Quercetin Nanoparticles for Multi‐Target Ferroptosis Inhibition in Parkinson's Disease. Advanced Science. 2026. doi:10.1002/advs.77025
BibTeX
@article{Xu2026,
author = {Xu, Keyang and Kou, Dandan and Xiao, Xiao and Bai, Bingbing and Liu, Caide and Wu, Mengyao and Shi, Yadan and Xu, Mengdan and Cao, Xiaoyi and Qi, Haodi and Wu, Shuhua and Zeng, Jianfeng and Gao, Mingyuan},
title = {Intranasal Delivery of Gallium–Quercetin Nanoparticles for Multi‐Target Ferroptosis Inhibition in Parkinson's Disease},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.77025}
}
EUVIMED